Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biologics Immunology & Analytics - BIA AB
AB
Active
Org 5592250277
Odengatan 31 B, 113 51
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2019
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biologics Immunology & Analytics - BIA AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
140
99
41
304
179
Staff expenses
—
−9
−1
−11
−11
EBITDA
92
48
16
267
148
Depreciation & amort.
−0
—
—
—
—
EBIT
92
48
16
267
148
Net financials
—
0
0
0
0
Profit before tax
92
48
16
267
149
Tax
−19
−10
−3
−55
−31
Net profit
73
38
13
212
118
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
453
276
175
485
541
Equity
416
255
167
379
498
Long-term debt
0
—
—
—
—
Short-term debt
36
22
7
106
43
Total debt
36
22
7
106
43
Financial ratios
5-year trend
EBITDA margin
82.8%
This company
15.8%
Market median
+424% vs market
2021
2025
Equity ratio
92.0%
This company
38.2%
Market median
+141% vs market
2021
2025
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
2021
2025
Net profit margin
66.0%
This company
8.1%
Market median
+715% vs market
2021
2025
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
2021
2025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Biologics Immunology & Analytics - BIA AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
